We are live on ! Find out more
JHMH

John Hancock Multifactor Healthcare ETF

Delisted

JHMH was delisted on the 24th of October, 2022.

0 hedge funds and large institutions have $0 invested in John Hancock Multifactor Healthcare ETF in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

57.99% less ownership

Funds ownership: 57.99% → 0% (-58%)

100% less funds holding

Funds holding: 22 → 0 (-22)

100% less capital inflows, than outflows

Capital inflows: $0 | Capital outflows: $21.5M

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 20

Holders
–
Holders Change
-22
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
20
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

JHMH Hedge Fund Activity: Q4 2022 in Review

0 of the 6,241 institutional investors tracked by Wall St. Rank reported a position in John Hancock Multifactor Healthcare ETF (JHMH) for Q4 2022, worth a combined $0 — down 100% from $21.5M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of JHMH and 0 opened new positions — a net loss of 20 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was LPL Financial, exiting entirely with an estimated $4.21M sold.

  • 0 institutional investors held John Hancock Multifactor Healthcare ETF (JHMH) as of Q4 2022, down from 22 in Q3 2022.
  • Funds reported $0 of John Hancock Multifactor Healthcare ETF stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new John Hancock Multifactor Healthcare ETF positions in Q4 2022 and 20 closed out, a net change of -20 holders.
  • The largest John Hancock Multifactor Healthcare ETF seller in Q4 2022 was LPL Financial, an estimated $4.21M sold.

Based on aggregated 13F filings for Q4 2022.